Impact of pharmacogenetics on docetaxel as neoadjuvant treatment of breast cancer.

被引：0
|
作者：
Xie, Hanjing
Bergh, Jonas C. S.
Hellstrom, Mats
Hatschek, Thomas
Sim, Sarah
机构：
[1] Karolinska Inst, Univ Hosp, Stockholm, Sweden
[2] Karolinska Univ Hosp, Stockholm, Sweden
[3] Karolinska Inst, Stockholm, Sweden
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.1067
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1067
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Pharmacogenetic impact of docetaxel on neoadjuvant treatment of breast cancer patients
    Sim, Sarah
    Bergh, Jonas
    Hellstroem, Mats
    Hatschek, Thomas
    Xie, Hanjing
    [J]. PHARMACOGENOMICS, 2018, 19 (16) : 1259 - 1268
  • [2] Docetaxel and anthracycline in neoadjuvant treatment of breast cancer. Efficacy evaluation according to molecular factors
    Szydlowska-Pazera, Katarzyna
    Potemski, Piotr
    Kubiak, Robert
    Pluzanska, Anna
    [J]. WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2007, 11 (07): : 360 - 366
  • [3] BENEFIT OF NEOADJUVANT DOCETAXEL IN TREATMENT OF BREAST CANCER
    Elmesidy, S.
    Atteya, H.
    Elkashif, A.
    HAmmam, W.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 73 - 74
  • [4] Docetaxel as adjuvant and neoadjuvant treatment for patients with breast cancer
    Heys, SD
    Sarkar, T
    Hutcheon, AW
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (10) : 2147 - 2157
  • [5] Gemcitabine and docetaxel in metastatic and neoadjuvant treatment of breast cancer
    Yardley, DA
    [J]. SEMINARS IN ONCOLOGY, 2004, 31 (02) : 37 - 44
  • [6] A different yet traditional approach to neoadjuvant treatment of breast cancer: The combination of epirubicin and docetaxel Neoadjuvant epirubicin docetaxel in breast cancer'
    Yuce, Elif
    Karakullukcu, Serdar
    Alandag, Celal
    Bulbul, Hatice
    Saygin, Ismail
    Kavgaci, Halil
    [J]. ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2023, 14
  • [7] Neoadjuvant treatment in breast cancer. Role of the pathologist
    Burgues, Octavio
    Terradez, Liria
    Buch, Elvira
    Teresa Martinez, Ma
    Miguel Cejalvo, Juan
    Bermejo, Begona
    [J]. REVISTA DE SENOLOGIA Y PATOLOGIA MAMARIA, 2022, 35 : S87 - S100
  • [8] Gene expression profiling to predict response to neoadjuvant docetaxel and capecitabine for breast cancer.
    Korde, L.
    Zujewski, J.
    McShane, L.
    Lukes, L.
    Lebowitz, P.
    Finney, R.
    Hunter, K.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S137 - S138
  • [9] Gemcitabine and docetaxel in metastatic and neoadjuvant treatment of breast cancer - Introduction
    McVie, G
    [J]. SEMINARS IN ONCOLOGY, 2004, 31 (02) : 1 - 1
  • [10] Pharmacogenetics of response to neoadjuvant paclitaxel treatment for locally advanced breast cancer
    Perez-Ortiz, Andric C.
    Ramirez, Israel
    Cruz-Lopez, Juan C.
    Villarreal-Garza, Cynthia
    Luna-Angulo, Alexandra
    Lira-Romero, Esmeralda
    Jimenez-Chaidez, Salvador
    Diaz-Chavez, Jose
    Matus-Santos, Juan A.
    Sanchez-Chapul, Laura
    Mendoza-Lorenzo, Patricia
    Estrada-Mena, Francisco J.
    [J]. ONCOTARGET, 2017, 8 (63) : 106454 - 106467
12345